Roche to Acquire PathAI for $750M to Enhance AI-Driven Diagnostics
Roche has entered into a definitive agreement to acquire PathAI for $750 million, enhancing its digital pathology capabilities.
Therapeutic Area
Therapeutic area intelligence for Digital Pathology with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.